Press "Enter" to skip to content

Gene Verified That Elevates Danger Of Antibiotic Reaction

Scientists at Vanderbilt University Medical Center and associates have verified a gene that elevates the danger for a potentially life-threatening and severe reaction to vancomycin (the frequently prescribed antibiotic). Regular testing for this gene can enhance patient safety and lower needless avoidance of other antibiotics, they claimed in the Journal of Allergy and Clinical Immunology.

“We believe this test will be significant in the clinical care of patients beginning with vancomycin and will stop short- and long-term as well as mortality complications,” claimed the senior author of the paper, Elizabeth Phillips, to the media in an interview. “This observation also shows significant development as we zero in on the methods of these immune-mediated life-threatening drug reactions,” she claimed.

Vancomycin is usually given as home intravenous therapy or in the hospital for various weeks together with other antibiotics to cure potentially life-threatening and serious bacterial infections. Within 2–8 Weeks of starting antibiotic treatment, on the other hand, some people got a severe reaction dubbed as Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) distinguished by widespread skin rash, fever, and internal organ injury caused by an abnormal T-cell mediated immune reaction to the drug.

On a related note, chemistry researchers at University of Colorado Boulder have designed a new method to optimize and synthesize a naturally-occurring antibiotic element that can someday be employed to deal with lethal drug-resistant diseases such as MRSA (Staphylococcus aureus).

Antibiotic-resistant diseases bother more than 2 Million users each year and lead to more than 23,000 deaths each year in the U.S., as per the CDC (Centers for Disease Control and Prevention). A study by the European counterpart of CDC discovered that drug-resistant infections were accountable for 33,000 deaths in 2015 all over Europe. Scientists have earlier verified a naturally-occurring antibiotic element, thiopeptides, as a promising result of research.

Vanessa Boone
Vanessa Boone Author
EDITOR & AUTHOR At Industry News USA

Vanessa Boone carries a total of 7 years experience in the healthcare domain. She owns a Master’s of Medicine Degree. She bagged numerous awards by contributing in the medical field with her ground-breaking notions. Vanessa has developed her own style of working and known for accuracy in her work. She loves trekking. She visits new places whenever she gets free time.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *